{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T12:27:32Z","timestamp":1786883252356,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360529"],"award-info":[{"award-number":["82360529"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary &amp; Pancreatic Diseases International"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.hbpd.2026.07.012","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:30:14Z","timestamp":1785799814000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Methyl-CpG-binding protein 2 facilitates progression of metabolic dysfunction-associated fatty liver disease via lactylation"],"prefix":"10.1016","author":[{"given":"Yu-Qing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Xian","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian-Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-Hua","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Qiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2026.07.012_bib0001","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.3350\/cmh.2022.0367","article-title":"MAFLD: how is it different from NAFLD?","volume":"29","author":"Gofton","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0002","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0003","first-page":"447","article-title":"Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment","volume":"111","author":"Wei\u00df","year":"2014","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0004","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1570161121666221118155136","article-title":"Non-alcoholic fatty liver disease in children","volume":"21","author":"Muzurovi\u0107","year":"2023","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0005","doi-asserted-by":"crossref","first-page":"7083","DOI":"10.1038\/s41598-025-91312-5","article-title":"Global burden of MAFLD, MAFLD related cirrhosis and MASH related liver cancer from 1990 to 2021","volume":"15","author":"Guo","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0006","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0007","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","article-title":"Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States","volume":"141","author":"Charlton","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0008","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0035-1562943","article-title":"Epidemiology and natural history of nonalcoholic fatty liver disease","volume":"35","author":"Satapathy","year":"2015","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0009","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0010","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.3390\/ijms26062758","article-title":"Non-alcoholic fatty liver disease (NAFLD) management in the community","volume":"26","author":"Park","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0011","doi-asserted-by":"crossref","first-page":"497","DOI":"10.5009\/gnl220276","article-title":"Fatty liver disease and cardiovascular risk: impact of metabolic dysfunctions","volume":"16","author":"Lee","year":"2022","journal-title":"Gut Liver"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0012","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ueg2.12525","article-title":"Therapeutic management of metabolic dysfunction associated steatotic liver disease","volume":"12","author":"Zeng","year":"2024","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0013","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41420-025-02705-4","article-title":"Roles of lactylation in lipid metabolism and related diseases","volume":"11","author":"Zhao","year":"2025","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0014","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0015","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/brv.13135","article-title":"Unlocking the multifaceted molecular functions and diverse disease implications of lactylation","volume":"100","author":"Jing","year":"2025","journal-title":"Biol Rev"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0016","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.cmet.2023.06.013","article-title":"Hexokinase 2-mediated gene expression via histone lactylation is required for hepatic stellate cell activation and liver fibrosis","volume":"35","author":"Rho","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0017","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s42255-022-00710-w","article-title":"Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma","volume":"5","author":"Yang","year":"2023","journal-title":"Nat Metab"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106270","article-title":"Demethylzeylasteral targets lactate by inhibiting histone lactylation to suppress the tumorigenicity of liver cancer stem cells","volume":"181","author":"Pan","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0019","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1097\/HEP.0000000000000279","article-title":"Mitochondrial pyruvate carrier 1 regulates fatty acid synthase lactylation and mediates treatment of nonalcoholic fatty liver disease","volume":"78","author":"Gao","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0020","doi-asserted-by":"crossref","first-page":"985","DOI":"10.33549\/physiolres.935289","article-title":"LDHA- mediated histone lactylation promotes the nonalcoholic fatty liver disease progression through targeting the METTL3\/YTHDF1\/SCD1 m6A axis","volume":"73","author":"Meng","year":"2024","journal-title":"Physiol Res"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0021","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41586-020-2574-4","article-title":"MeCP2 links heterochromatin condensates and neurodevelopmental disease","volume":"586","author":"Li","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0022","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13023-016-0545-5","article-title":"Rett syndrome\u2013biological pathways leading from MECP2 to disorder phenotypes","volume":"11","author":"Ehrhart","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0023","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.neuron.2024.04.007","article-title":"MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons","volume":"112","author":"Liu","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0024","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.3390\/cancers15102683","article-title":"The epigenetic reader methyl-CpG-binding protein 2 (MeCP2) is an emerging oncogene in cancer biology","volume":"15","author":"Nejati-Koshki","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0025","article-title":"MeCP2 lactylation protects against ischemic brain injury by transcriptionally regulating neuronal apoptosis","volume":"12","author":"Sun","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0026","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.7150\/thno.94738","article-title":"Methyl-CpG-binding 2 K271 lactylation-mediated M2 macrophage polarization inhibits atherosclerosis","volume":"14","author":"Chen","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0027","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.atherosclerosis.2023.05.009","article-title":"Exercise-induced endothelial Mecp2 lactylation suppresses atherosclerosis via the Ereg\/MAPK signalling pathway","volume":"375","author":"Wang","year":"2023","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0028","article-title":"Epigenetics of alcohol-related liver diseases","volume":"4","author":"Habash","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0029","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tox.2013.04.008","article-title":"The role of methyl-CpG binding protein 2 in liver fibrosis","volume":"309","author":"Bian","year":"2013","journal-title":"Toxicology"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0030","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/carcin\/bgg163","article-title":"Methyl deficiency causes reduction of the methyl-CpG-binding protein, MeCP2, in rat liver","volume":"24","author":"Esfandiari","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0031","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.cellsig.2013.01.005","article-title":"DNA methylation and MeCP2 regulation of PTCH1 expression during rats hepatic fibrosis","volume":"25","author":"Yang","year":"2013","journal-title":"Cell Signal"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0032","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2009.10.002","article-title":"MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis","volume":"138","author":"Mann","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0033","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0034","doi-asserted-by":"crossref","first-page":"D330","DOI":"10.1093\/nar\/gky1055","article-title":"The gene ontology resource: 20 years and still GOing strong","volume":"47","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2024.114863","article-title":"POMC-specific knockdown of MeCP2 leads to adverse phenotypes in mice chronically exposed to high fat diet","volume":"461","author":"Frayre","year":"2024","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0037","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41573-021-00367-2","article-title":"Lipogenesis inhibitors: therapeutic opportunities and challenges","volume":"21","author":"Batchuluun","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0038","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1210\/er.2018-00064","article-title":"Molecular actions of PPAR\u03b1 in lipid metabolism and inflammation","volume":"39","author":"Bougarne","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2025.101535","article-title":"Lactate facilitates pancreatic repair following acute pancreatitis by promoting reparative macrophage polarization","volume":"19","author":"Jiang","year":"2025","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0040","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/ng.2714","article-title":"A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome","volume":"45","author":"Buchovecky","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0041","first-page":"3029","article-title":"MeCP2 co-ordinates liver lipid metabolism with the NCoR1\/HDAC3 corepressor complex","volume":"25","author":"Kyle","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0042","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3892\/ijmm.2024.5383","article-title":"Role of lactate and lactate metabolism in liver diseases (Review)","volume":"54","author":"Yao","year":"2024","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210184","article-title":"High-fat diet accelerates extreme obesity with hyperphagia in female heterozygous Mecp2-null mice","volume":"14","author":"Fukuhara","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0044","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13195-020-00616-3","article-title":"Reduction of NgR in perforant path decreases amyloid-\u03b2 peptide production and ameliorates synaptic and cognitive deficits in APP\/PS1 mice","volume":"12","author":"Jiang","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0045","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature14580","article-title":"Genetic compensation induced by deleterious mutations but not gene knockdowns","volume":"524","author":"Rossi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.hbpd.2026.07.012_bib0046","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2025.3","article-title":"Lactylation and human disease","volume":"27","author":"Wan","year":"2025","journal-title":"Expert Rev Mol Med"}],"container-title":["Hepatobiliary &amp; Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387226001220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387226001220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T11:25:12Z","timestamp":1786879512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387226001220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":46,"alternative-id":["S1499387226001220"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2026.07.012","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methyl-CpG-binding protein 2 facilitates progression of metabolic dysfunction-associated fatty liver disease via lactylation","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2026.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}